Last 12 months
Inside the activity.
0 purchase rows · 9 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2024 Filed Feb 1, 2024 02:37 UTC |
Mashiach NissimDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001104659-24-009031 · tm244775-15_4seq1.xml · derivative · entry 1 Mashiach Nissim · CIK 0001357777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-29 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 02:36 UTC |
Dietz Thomas JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001104659-24-009030 · tm244775-8_4seq1.xml · derivative · entry 1 Dietz Thomas John · CIK 0001574218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-01-29 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 02:36 UTC |
Schilsky RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001104659-24-009029 · tm244775-14_4seq1.xml · derivative · entry 1 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-29 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 02:35 UTC |
Baum JasonChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001104659-24-009027 · tm244775-6_4seq1.xml · derivative · entry 1 Baum Jason · CIK 0001970907 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2034-01-29 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of January 29, 2024. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 02:35 UTC |
Richard Christian MDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001104659-24-009026 · tm244775-13_4seq1.xml · derivative · entry 1 Richard Christian M · CIK 0001645967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-29 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 02:34 UTC |
Martin Patricia A.Director
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001104659-24-009023 · tm244775-12_4seq1.xml · derivative · entry 1 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2034-01-29 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 20:39 UTC |
Sirard CynthiaChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-008419 · tm244628-3_4seq1.xml · derivative · entry 2 Sirard Cynthia · CIK 0001808408 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 20:39 UTC |
Sirard CynthiaChief Medical Officer
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-008419 · tm244628-3_4seq1.xml · nonDerivative · entry 1 Sirard Cynthia · CIK 0001808408 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 20:41 UTC |
O'Mahony John MarkChief Manufacturing Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-008420 · tm244628-4_4seq1.xml · derivative · entry 2 O'Mahony John Mark · CIK 0001808556 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. F3 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 20:41 UTC |
O'Mahony John MarkChief Manufacturing Officer
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-008420 · tm244628-4_4seq1.xml · nonDerivative · entry 1 O'Mahony John Mark · CIK 0001808556 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:37 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
|
Exercise / conversionRestricted Stock Units · Derivative | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-008417 · tm244628-1_4seq1.xml · derivative · entry 3 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 7,500 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. F4 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 7,500 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:37 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
|
Exercise / conversionCommon Stock | 7,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-008417 · tm244628-1_4seq1.xml · nonDerivative · entry 1 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 20:42 UTC |
Mirabelli ChristopherDirector · Chairman of the Board
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-008421 · tm244628-5_4seq1.xml · derivative · entry 3 Mirabelli Christopher · CIK 0001262326 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. F4 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. Read SEC document |
| January 26, 2024 Filed Jan 30, 2024 20:42 UTC |
Mirabelli ChristopherDirector · Chairman of the Board
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-008421 · tm244628-5_4seq1.xml · nonDerivative · entry 1 Mirabelli Christopher · CIK 0001262326 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:38 UTC |
LAWLOR AUGUSTINEChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-008418 · tm244628-2_4seq1.xml · derivative · entry 4 LAWLOR AUGUSTINE · CIK 0001262327 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. F5 · derivative.expiration_date: On January 26, 2021, the reporting person was granted 5,000 Restricted Stock Units, vesting on January 26, 2024 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. Read SEC document |
| January 26, 2024 Filed Jan 31, 2024 01:38 UTC |
LAWLOR AUGUSTINEChief Operating Officer
|
Exercise / conversionCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-008418 · tm244628-2_4seq1.xml · nonDerivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. F2 · balance_after: The share numbers reflected in Tables I and II have been adjusted to take into account a 10-for-1 reverse stock split of the Company's common stock that was effected on June 20, 2023. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:30 UTC |
Granfield ChristineVP, Head of Reg Affairs/Qual
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095369 · tm2324823-15_4seq1.xml · derivative · entry 1 Granfield Christine · CIK 0001822190 · VP, Head of Reg Affairs/Qual 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:30 UTC |
CAVANAUGH JAMES HDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095360 · tm2324823-6_4seq1.xml · derivative · entry 1 CAVANAUGH JAMES H · CIK 0001013473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:30 UTC |
Sirard CynthiaChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095366 · tm2324823-12_4seq1.xml · derivative · entry 1 Sirard Cynthia · CIK 0001808408 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:30 UTC |
O'Mahony John MarkChief Manufacturing Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095367 · tm2324823-13_4seq1.xml · derivative · entry 1 O'Mahony John Mark · CIK 0001808556 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:31 UTC |
LI WILLIAMDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095362 · tm2324823-8_4seq1.xml · derivative · entry 1 LI WILLIAM · CIK 0001273806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:30 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 140,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095363 · tm2324823-9_4seq1.xml · derivative · entry 1 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:31 UTC |
LAWLOR AUGUSTINEChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095365 · tm2324823-11_4seq1.xml · derivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:31 UTC |
Mirabelli ChristopherDirector · Chairman of the Board
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095364 · tm2324823-10_4seq1.xml · derivative · entry 1 Mirabelli Christopher · CIK 0001262326 · Director · Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:30 UTC |
LOSCALZO JOSEPHDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095359 · tm2324823-5_4seq1.xml · derivative · entry 1 LOSCALZO JOSEPH · CIK 0001276128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:31 UTC |
Mashiach NissimDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095357 · tm2324823-3_4seq1.xml · derivative · entry 1 Mashiach Nissim · CIK 0001357777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:31 UTC |
Dietz Thomas JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095361 · tm2324823-7_4seq1.xml · derivative · entry 1 Dietz Thomas John · CIK 0001574218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:31 UTC |
Martin Patricia A.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095358 · tm2324823-4_4seq1.xml · derivative · entry 1 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:31 UTC |
Richard Christian MDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095356 · tm2324823-2_4seq1.xml · derivative · entry 1 Richard Christian M · CIK 0001645967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:30 UTC |
Schilsky RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095355 · tm2324823-1_4seq1.xml · derivative · entry 1 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of November 23, 2023, February 23, 2024, May 23, 2024 and August 23, 2024 for so long as the reporting person continues to be a director, consultant or service provider of the Company. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 20:30 UTC |
Baum JasonChief Scientific Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $2.21 | $0.00 |
DisclosureSEC source: 0001104659-23-095368 · tm2324823-14_4seq1.xml · derivative · entry 1 Baum Jason · CIK 0001970907 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2033-08-23 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:15 UTC |
Granfield ChristineVP, Head of Reg Affairs/Qual
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041752 · tm2311741-11_4seq1.xml · derivative · entry 1 Granfield Christine · CIK 0001822190 · VP, Head of Reg Affairs/Qual 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:14 UTC |
CAVANAUGH JAMES HDirector
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041749 · tm2311741-8_4seq1.xml · derivative · entry 1 CAVANAUGH JAMES H · CIK 0001013473 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:17 UTC |
Sirard CynthiaChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041754 · tm2311741-14_4seq1.xml · derivative · entry 1 Sirard Cynthia · CIK 0001808408 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:17 UTC |
O'Mahony John MarkChief Manufacturing Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041753 · tm2311741-13_4seq1.xml · derivative · entry 1 O'Mahony John Mark · CIK 0001808556 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:14 UTC |
LI WILLIAMDirector
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041750 · tm2311741-9_4seq1.xml · derivative · entry 1 LI WILLIAM · CIK 0001273806 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:10 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 750,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041743 · tm2311741-2_4seq1.xml · derivative · entry 1 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:09 UTC |
LAWLOR AUGUSTINEChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041741 · tm2311741-1_4seq1.xml · derivative · entry 1 LAWLOR AUGUSTINE · CIK 0001262327 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date. Read SEC document |
| March 31, 2023 Filed Apr 4, 2023 20:18 UTC |
Mirabelli ChristopherDirector
|
GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041755 · tm2311741-12_4seq1.xml · derivative · entry 1 Mirabelli Christopher · CIK 0001262326 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on the one month anniversary of March 31, 2023, the Vesting Start Date. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:15 UTC |
LOSCALZO JOSEPHDirector
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041751 · tm2311741-10_4seq1.xml · derivative · entry 1 LOSCALZO JOSEPH · CIK 0001276128 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:11 UTC |
Mashiach NissimDirector
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041744 · tm2311741-3_4seq1.xml · derivative · entry 1 Mashiach Nissim · CIK 0001357777 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:13 UTC |
Schilsky RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041748 · tm2311741-7_4seq1.xml · derivative · entry 1 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:12 UTC |
Dietz Thomas JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041747 · tm2311741-6_4seq1.xml · derivative · entry 1 Dietz Thomas John · CIK 0001574218 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:12 UTC |
Martin Patricia A.Director
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041746 · tm2311741-5_4seq1.xml · derivative · entry 1 Martin Patricia A. · CIK 0001916764 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 00:11 UTC |
Richard Christian MDirector
|
GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001104659-23-041745 · tm2311741-4_4seq1.xml · derivative · entry 1 Richard Christian M · CIK 0001645967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 4 quarterly installments on each of March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023 for so long as the reporting person continues to be a director, consultant or service provider of the Company until the Option is fully vested. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:05 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
|
Exercise / conversionRestricted Stock Units · Derivative | 660,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-035047 · tm2310117-1_4seq1.xml · derivative · entry 3 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 660,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Stock Units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On March 17, 2020, the reporting person was granted 660,606 Restricted Stock Units, vesting on March 17, 2023 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. F3 · derivative.expiration_date: On March 17, 2020, the reporting person was granted 660,606 Restricted Stock Units, vesting on March 17, 2023 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit. Read SEC document |
| March 17, 2023 Filed Mar 21, 2023 20:05 UTC |
ONSI DOUGLAS EDirector · CEO,CFO,Pres.,GC,Treas.,&Sec.
|
Exercise / conversionCommon Stock | 660,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-035047 · tm2310117-1_4seq1.xml · nonDerivative · entry 1 ONSI DOUGLAS E · CIK 0001270185 · Director · CEO,CFO,Pres.,GC,Treas.,&Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 661,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Stock Units convert into common stock on a one-for-one basis. Read SEC document |
| September 06, 2022 Filed Sep 9, 2022 01:35 UTC |
Schilsky RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.62 | $0.00 |
DisclosureSEC source: 0001104659-22-098627 · tm2225478-2_4seq1.xml · derivative · entry 1 Schilsky Richard · CIK 0001945662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-09-06 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of equal quarterly installments for 12 quarters, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 21:29 UTC |
Granfield ChristineVP, Head of Reg Affairs/Qual
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001104659-22-097622 · tm2225099-11_4seq1.xml · derivative · entry 1 Granfield Christine · CIK 0001822190 · VP, Head of Reg Affairs/Qual 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-08-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 36 equal monthly installments until the Option is fully vested, with the first such monthly installment vesting on the one month anniversary of September 1, 2022, the Vesting Start Date. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 21:41 UTC |
CAVANAUGH JAMES HDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.43 | $0.00 |
DisclosureSEC source: 0001104659-22-097623 · tm2225099-4_4seq1.xml · derivative · entry 1 CAVANAUGH JAMES H · CIK 0001013473 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-08-31 F1 · derivative.exercise_date: The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.